Thymus Cancer

News alerts, weekly reports and conference planners

Related cancers:

‹

Thymic Carcinoma (32)

Thymoma (21)

Thymic Carcinoma (32)

Thymoma (21)

›

No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	lenvatinib Sensitive: A1 - Approval lenvatinib Sensitive : A1	lenvatinib Sensitive: A1 - Approval lenvatinib Sensitive : A1
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	GEM-CAP Sensitive: A2 - Guideline GEM-CAP Sensitive : A2	GEM-CAP Sensitive: A2 - Guideline GEM-CAP Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	LV5FU2 Sensitive: A2 - Guideline LV5FU2 Sensitive : A2	LV5FU2 Sensitive: A2 - Guideline LV5FU2 Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	GEM-CAP Sensitive: A2 - Guideline GEM-CAP Sensitive : A2	GEM-CAP Sensitive: A2 - Guideline GEM-CAP Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	LV5FU2 Sensitive: A2 - Guideline LV5FU2 Sensitive : A2	LV5FU2 Sensitive: A2 - Guideline LV5FU2 Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	CaT Sensitive: A2 - Guideline CaT Sensitive : A2	CaT Sensitive: A2 - Guideline CaT Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	CaT Sensitive: A2 - Guideline CaT Sensitive : A2	CaT Sensitive: A2 - Guideline CaT Sensitive : A2
KIT mutation	Thymic Carcinoma	KIT mutation	Thymic Carcinoma	sunitinib Sensitive: A2 - Guideline sunitinib Sensitive : A2	sunitinib Sensitive: A2 - Guideline sunitinib Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	VIP Sensitive: A2 - Guideline VIP Sensitive : A2	VIP Sensitive: A2 - Guideline VIP Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	VIP Sensitive: A2 - Guideline VIP Sensitive : A2	VIP Sensitive: A2 - Guideline VIP Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	CAP Sensitive: A2 - Guideline CAP Sensitive : A2	CAP Sensitive: A2 - Guideline CAP Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2	etoposide IV Sensitive: A2 - Guideline etoposide IV Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	EP Sensitive: A2 - Guideline EP Sensitive : A2	EP Sensitive: A2 - Guideline EP Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	ADOC Sensitive: A2 - Guideline ADOC Sensitive : A2	ADOC Sensitive: A2 - Guideline ADOC Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	CAP + prednisone Sensitive: A2 - Guideline CAP + prednisone Sensitive : A2	CAP + prednisone Sensitive: A2 - Guideline CAP + prednisone Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	CAP Sensitive: A2 - Guideline CAP Sensitive : A2	CAP Sensitive: A2 - Guideline CAP Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	CAP + prednisone Sensitive: A2 - Guideline CAP + prednisone Sensitive : A2	CAP + prednisone Sensitive: A2 - Guideline CAP + prednisone Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	ADOC Sensitive: A2 - Guideline ADOC Sensitive : A2	ADOC Sensitive: A2 - Guideline ADOC Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	EP Sensitive: A2 - Guideline EP Sensitive : A2	EP Sensitive: A2 - Guideline EP Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	paclitaxel Sensitive: A2 - Guideline paclitaxel Sensitive : A2	paclitaxel Sensitive: A2 - Guideline paclitaxel Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2	carboplatin Sensitive: A2 - Guideline carboplatin Sensitive : A2
No biomarker	Thymoma	No biomarker	Thymoma	pembrolizumab Resistant: A2 - Guideline pembrolizumab Resistant : A2	pembrolizumab Resistant: A2 - Guideline pembrolizumab Resistant : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2	ifosfamide Sensitive: A2 - Guideline ifosfamide Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	pembrolizumab Sensitive: A2 - Guideline pembrolizumab Sensitive : A2	pembrolizumab Sensitive: A2 - Guideline pembrolizumab Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	gemcitabine Sensitive: A2 - Guideline gemcitabine Sensitive : A2	gemcitabine Sensitive: A2 - Guideline gemcitabine Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	prednisone + octreotide Sensitive: A2 - Guideline prednisone + octreotide Sensitive : A2	prednisone + octreotide Sensitive: A2 - Guideline prednisone + octreotide Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	octreotide Sensitive: A2 - Guideline octreotide Sensitive : A2	octreotide Sensitive: A2 - Guideline octreotide Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	everolimus Sensitive: A2 - Guideline everolimus Sensitive : A2	everolimus Sensitive: A2 - Guideline everolimus Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	pemetrexed Sensitive: A2 - Guideline pemetrexed Sensitive : A2	pemetrexed Sensitive: A2 - Guideline pemetrexed Sensitive : A2

Thymus Cancer

Associations(53)

Associations
(53)